Boston Scientific (NYSE:BSX) is warning healthcare providers that patients implanted with certain of its older Emblem S-ICD cardioverter defibrillators may need early revision surgery due to premature battery depletion.
The company expanded on an August 2019 advisory about 350 of its Emblem S-ICD models A209 and A219 to include approximately 38,350 active devices. The devices contain a low-voltage capacitor that may cause their batteries to drain too quickly. A company analysis of returned devices indicates that at least three months of battery capacity remain before the battery runs out.
